The allogeneic response to cultured human skin equivalent in the hu- PBL-SCID mouse model of skin rejection

Transplantation

Volumn 67, Issue 12, 1999, Pages 1590-1599

  Briscoe, David M ^a   Dharnidharka, Vikas R ^a   Isaacs, Cary ^b   Downing, Greg ^b   Prosky, Stefan ^b   Shaw, Peter ^a   Parenteau, Nancy L ^b   Hardin Young, Janet ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ORGANOGENESIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TRANSPLANTATION; T LYMPHOCYTE; VASCULARIZATION; VASCULITIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; ISOANTIGENS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, SCID; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032975257     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199906270-00014     Document Type: Article

References (47)

1. Parenteau NL, Bilbo P, Nolte CJ, Mason VS, Rosenberg M. The organotypic culture of human skin keratinocytes and fibroblasts to achieve form and function. Cytotechnology 1992; 9: 163.
2. Parenteau NL, Nolte CM, Bilbo P, et al. Epidermis generated in vitro: practical considerations and applications. J Cell Biochem 1991; 45: 245.
3. Machluf M, Atala A. Tissue engineering: emerging concepts. Graft 1998; 1: 31.
4. Parenteau NL. Skin equivalents. In: Leigh I, Watts F, eds. Keratinocyte methods, Cambridge: Cambridge University Press, 1994: 45.
5. Nolte CJ, Oleson MA, Bilbo PR, Parenteau NL. Development of a stratum corneum and barrier function in an organotypic skin culture. Arch Dermatol Res 1993; 285: 466.
6. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998; 134: 293.
7. Aubock J, Irschick E, Romani N, et al. Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans. Transplantation 1988; 45: 730.
8. Cairns BA, deSerres S, Matsui M, Frelinger JA, Meyer AA. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response. Transplantation 1994; 58: 67.
9. Carver N, Navsaria HA, Green CJ, Leigh IM. Acute rejection of cultured keratinocyte allografts in nonimmunosuppressed pigs. Transplantation 1991; 52: 918.
10. Krensky AM, Weiss A, Crabtree G, Davis M, Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 1990; 322: 510.
11. Krieger NR, Yin D, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
12. Sayegh MH, Turka LA. The role of T cell costimulatory activation in transplant rejection. N Engl J Med 1998; 338: 1813.
13. Kupper TS. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 1990; 86: 1783.
14. Williams IR, Kupper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 1996; 58: 1485.
15. Briscoe DM, Cotran RS. Endothelial cells in immune inflammation. In: Therapeutic Immunology, Austen KF, Bruakoff SJ, Rosen FS, Strom TB, eds. Cambridge: Blackwell Scientific Publications, 1996: 12.
16. Morhenn VB, Nickoloff BJ. Interleukin-2 stimulates resting human T lymphocytes' response to allogeneic, gamma interferon-treated keratinocytes. J Invest Dermatol 1987; 89: 464.
17. Niederwieser D, Aubock J, Troppmair J, et al. IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol 1988; 140: 2556.
18. Gaspari AA, Katz SI. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. J Immunol 1991; 147: 4155.
19. Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994; 15: 464.
20. Theobald VA, Lauer JD, Kaplan FA, Baker KB, Rosenberg M. "Neutral allografts" - lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens. Transplantation 1993; 55: 128.
21. Cairns BA, deSerres S, Kilpatrick K, Frelinger JA, Meyer AA. Cultured keratinocyte allografts fail to induce sensitization in vivo. Surgery 1993; 114: 416.
22. Thivolet J, Faure M, Demidem A, Mauduit G. Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation 1986; 42: 274.
23. Kawamura T, Niguma T, Fetchner JH Jr, et al. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor. Transplantation 1992; 53: 659.
24. Alegre ML, Peterson LJ, Jeyarajah DR, Weiser M, Bluestone JA, Thistlewaite JR. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol 1994; 153: 2738.
25. Murray AG, Petzelbauer P, Hughes CC, Costa J, Askenase P, Pober JS. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci USA 1994; 91: 9146.
26. Reul RM, Fang JC, Denton MD, et al. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 1997; 64: 1765.
27. Ausubel F, Brent R, Kingston RE, et al. Short protocols in molecular biology. New York: John Wiley and Sons, Inc. 1995.
28. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM. Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation 1999; 67: 1626.
29. Tary-Lehmann M, Saxon A, Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol Today 1995; 16: 529.
30. Sultan P, Schechner JS, McNiff JM, et al. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Natl Biotechnol 1997; 15: 759.
31. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256.
32. Torbett BE, Picchio G, Mosier DE. hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol Rev 1991; 124: 139.
33. Renz JF, Lin Z, de Roos M, Dalal AA, Ascher NL. SCID mouse as a model for transplantation studies. J Surg Res 1996; 65: 34.
34. Unanue ER, Cerottini JC. Antigen presentation. FASEB J 1989; 3: 2496.
35. Abbas AK, Williams ME, Burstein HJ, Chang T, Bossu P, Lichtman AH. Activation and functions of CD4+ T cell subsets. Immunol Rev 1991; 123: 5.
36. Weaver CT, Unanue ER. The costimulatory function of antigen presenting cells. Immunol Today 1990; 11: 49.
37. Jenkins MK. The ups and downs of T cell costimulation. Immunity 1994; 1: 443.
38. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996; 335: 1369.
39. Nickolof BJ, Mitra RS, Green J, et al. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte-function associated antigen-1/intercellular adhesion molecules-1 interaction. J Immunol 1993; 150: 2148.
40. Goodman RE, Nestle F, Naidu YM, et al. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J Immunol 1994; 152: 5189.
41. Pober JS, Orosz CG, Rose ML, Savage COS. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343.
42. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 57: 1295.
43. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
44. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480.
45. Ferrero E, Bondanza A, Leone BE, Manici S, Poggi A, Zocchi MR. CD14+ CD34+ peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells. J Immunol 1998; 160: 2675.
46. Vallee I, Guillaumin JM, Thibault G, et al. Human T lymphocyte proliferative response to resting porcine endothelial cells resuits from an HLA-restricted, IL-10-sensitive, indirect presentation pathway but also depends on endothelial-specific costimulatory factors. J Immunol 1998; 161: 1652.
47. Valujskikh A, Matesic D, Gilliam A, Anthony D, Haqqi TM, Heeger PS. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998; 101: 1398.